Enhanche Your Endo-SCOPE
OTTek - The Company
OTTek, a state-of-the-art innovative practical GI endoscopy solutions, medical device company, has developed the FIOT (Flow In Over Tube), a versatile, on-demand, easy-to-assemble, cost-effective, colonoscopy assist device.
The FIOT is designed to reduce the risks resulting from poor visualization in an insufficiently prepared colon and to facilitate successful completion of the procedure.
Market & Need
15 million people undergo colonoscopy annually in the US (~30 million WW). Approximately 10% of these procedures are performed in hospitals. Studies suggest that over 50% of the in-patients (hospitalized) and about 25% of the outpatients, undergoing colonoscopy have inadequate bowel preparation, which raises the need to resolve the following:
• Impaired visualization and reduced ability to detect and remove polyps and cancerous tissues
• Increased risk of incomplete colonoscopy, requiring repeat procedure or shortened follow-up intervals
• Delayed diagnosis and treatment, prolonged hospitalization and their associated direct and indirect costs
The Technology and The Product
The FIOT creates a working channel wider than the endoscope for rapid, efficient and unprecedented cleansing.
Single use device, compatible with most endoscopes, the FIOT functions as an “everting hollow tube, to further improve the colonoscopy procedure by:
- Higher polyp detection rate
- Easy and rapid repositioning when large polyp removal requires full withdrawal of the endoscope
- Rapid cleansing in cases of severe colon bleeding
- Stabilization of the endoscope during polyp removal
- Protection of the colon wall and prevention of endoscope looping
- Easy maneuvering and improved ability to reach the caecum
- Safe removal of entire cancerous polyps through the FIOT lumen
- Easy exchanging of instruments, supporting advanced colonoscopy.
The FIOT is designed to overcome critical endoscopy challenges, improving both clinical outcomes and healthcare economics:
- Higher colonoscopy completion rate, preventing repeat procedures
- Improved efficacy
- Fewer adverse events, e.g. perforation
- Improved cost-effectiveness by preventing the need for additional procedures and prolonged hospitalization
- Decrease the need for open or laparoscopic surgery
Inventor and CEO ,Over 25 years’ experience as team member, leader and manager in the development of medical systems (Biosense Webster, EPD Medical), industrial systems (Scitex, Creo, InkSure), and military systems (Elop). Inventor and co-inventor of over 20 patents in optics, mechanics and electronics. BSc Electronic Engineering, Tel Aviv University; MBA, Bar-Ilan University.
CEO & Managing Partner at NGT3 VC, Board Member
Managing Partner & CEO of NGT3VC. Former CEO & director of Beta-O2 Technologies (developed proprietary implantable bio-artificial pancreas). Served as CEO of the Technion Technological Incubator for 11 years. Led the establishment and investment in 53 companies, such as Prolor Biotech (sold to OPKO, $480M), Mazor Robotics (Sold to Medtronic, $1.6B), ReWalk (NASDAQ: RWLK), Corindus (Sold to Siemens, $1.1B), and many others.
CFO and Board Member at NGT3 VC , CFO of over 30 start-up companies since joining NGT3 in 2006, Nizar has hands-on financial management experience at all levels: from seed investment through early and late financial rounds.
Dr. Amir Toren
CTO and BD at NGT3 VC, Business Development , Over 18 years in executive management positions in the medical device and healthcare industries, including MediWound (R&D manager), Pluristem (VP BD), and extensive experience in CEO positions
(Coeruleus, JPMed and StarletDerma).
Prof. Haim Shirin
Advisory board , Head of Gastroenterology and Liver Disease Institute at Shamir M.C Israel.
Prof. Haim Shirin is a graduate "cum laude" of the Medicine Faculty at the Israel Institute of Technology and qualified in 1986. After his gastroenterology residency he did a post-doc fellowship at the Columbia University in New-York. Since 2011 he is the Head of Gastroenterology and Liver Disease Institute at Shamir M.C., in Israel. Prof. Shirin is an associated professor in Tel-Aviv University and published 94 original papers in peer review journals, many of them in high quality and high IF journals, and presented his studies in national and international meetings. Recently, he has been elected as the President of the Israeli Gastroenterology Association.
Director of Strategy , Entrepreneur, inventor and medical device industry executive for past 20 years, having in-depth experience in managing and creating value for medical device companies. Specialized in developing and introducing a wide range of medical technologies to market, strategic planning, strategic collaborating and M&A’s.
In 2009 David established Stimatix GI and serves as its CEO. In 2014, Stimatix assets were acquired by B.Braun. Prior to Stimatix David served as V.P. of R&D Vision Sciences Inc., a N.Y.-based medical device company specializing in flexible endoscopy. Prior to Vision Sciences Inc. he served as COO and R&D leader at CByond (Olympus-Gyrus-ACMI subsidiary) specializing in minimal invasive surgery.
To date, David published 23 patents applications of which 18 been granted.
David holds an MBA from Haifa University and a B.Sc. electrical engineering from Ben-Gurion University of the Negev (honors).
M : +972-54-7766632
E : yoav@OTTek-gi.com
13 Wadi el-Haj Nazareth 1610000